Treatment of Insomnia with Zaleplon in HIV+ Significantly Improves Sleep and Depression

Name: Treatment of Insomnia with Zaleplon in HIV+ Significantly Improves Sleep and Depression
SKU: 24335
Price: 30.00 USD
Availability: InStock

$30.00

Want a discount? Become a member by purchasing Psychopharmacology Bulletin Subscription - Individual!

Categories: Psychopharmacology Bulletin, VOL 51 No. 3 Articles 2021 Tags: Aalim Weljie, Anup Sharma, Arjun Sengupta, depression, hiv, insomnia, Jennifer R. Goldschmied, Knashawn H. Morales, Lynne Taylor, Matthew S. Kayser, metabolomics, michael-e-thase, zaleplon

Description

Description

Original Research

Treatment of Insomnia with Zaleplon in HIV+ Significantly Improves Sleep and Depression

By Jennifer R. Goldschmied, Arjun Sengupta, Anup Sharma, Lynne Taylor, Knashawn H. Morales, Michael E. Thase, Aalim Weljie, and Matthew S. Kayser

Treatment of Insomnia with Zaleplon in HIV+ Significantly Improves Sleep and Depression

Description

Original Research

Efficacy of Omega-3 Fatty Acids in Mood Disorders

In Vivo Neuroimaging Correlates of the Efficacy of Paroxetine in the Treatment of Mood and Anxiety Disorders

Assessment of Anxiety in Clinical Trials with Depressed Patients

Boadie W. Dunlop – Exercise for Depression: Efficacy, Safety and Clinical Trial Implications

Treatment of Insomnia with Zaleplon in HIV+ Significantly Improves Sleep and Depression

Description

Original Research

Related products

Efficacy of Omega-3 Fatty Acids in Mood Disorders

In Vivo Neuroimaging Correlates of the Efficacy of Paroxetine in the Treatment of Mood and Anxiety Disorders

Assessment of Anxiety in Clinical Trials with Depressed Patients

Boadie W. Dunlop – Exercise for Depression: Efficacy, Safety and Clinical Trial Implications